Showing results (121-130 of 194) with videos related to
Sort By:
Pageof 20
Journal of the International AIDS Society|January 7, 2022
Sex modifies the association between HIV and coronary artery disease among older adults in UgandaChris T Longenecker, Milana Bogorodskaya, Seunghee Margevicius, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|June 23, 2011
Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations; two arguments for viral load monitoring in AfricaKim C E Sigaloff, Raph L Hamers, Carole L Wallis, et al.AIDS Research and Human Retroviruses|May 2, 2012
Response to antiretroviral therapy of HIV type 1-infected children in urban and rural settings of UgandaVictor Musiime, Joshua Kayiwa, Mary Kiconco, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 9, 2026
CMV viraemia is associated with mortality among children with HIV starting antiretroviral therapy in sub-Saharan AfricaTemitope Fisayo, Ceri Evans, Kuda Mutasa, et al.AIDS Research and Human Retroviruses|January 3, 2016
HIV Drug Resistance Among Children Initiating First-Line Antiretroviral Treatment in UgandaCissy Kityo, Kim Catherina Eve Sigaloff, Tamara Sonia Boender, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|October 15, 2019
Switching to Fixed-Dose Bictegravir, Emtricitabine, and Tenofovir Alafenamide (B/F/TAF) in Virologically Suppressed HIV-1 Infected Women: A Randomized, Open-Label, Multicenter, Active-Controlled, Phase 3, Noninferiority TrialCissy Kityo, Debbie Hagins, Ellen Koenig, et al.The Lancet. Infectious Diseases|November 8, 2017
Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trialJames G Hakim, Jennifer Thompson, Cissy Kityo, et al.Open Forum Infectious Diseases|March 20, 2026
Associations Between B-Cell Subsets and Subclinical Coronary Artery Disease in Ugandans With and Without HIVLaventa M Obare, Tecla M Temu, Tan Ding, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2018
Late Presentation With HIV in Africa: Phenotypes, Risk, and Risk Stratification in the REALITY TrialAbraham Siika, Leanne McCabe, Mutsa Bwakura-Dangarembizi, et al.AIDS Research and Human Retroviruses|March 23, 2013
Short communication: high rates of thymidine analogue mutations and dual-class resistance among HIV-infected Ugandan children failing first-line antiretroviral therapyKim C E Sigaloff, Joshua Kayiwa, Victor Musiime, et al.Pageof 20